Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skin ulcer study backs LAM's would gel:

This article was originally published in Clinica

Executive Summary

LAM Pharmaceutical says that a study of its wound healing gel LAM IMP has shown positive results. The 24-week study showed a healing rate of 88% in 53 hard-to-heal skin ulcers treated with gel. All the patients had ulcers that had failed to respond to other forms of treatment for at least four weeks before they were enrolled in the study, notes the Lewiston, New York firm. The findings are scheduled for presentation at the Annual Symposium on Advanced Wound Care meeting in Baltimore, Maryland, next month.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel